Delivering Telegenetics Services: Review and Synthesis of Best Practices
Telemedicine and e-Health · 2024
DOI: 10.1089/tmj.2024.0110 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Telemedicine and e-Health, 2024. Verfasst von David Flannery und 10 weiteren Autor:innen. Beteiligte Einrichtung: Division of Medical Genetics and Genomics, Medical Specialties Institute Cleveland Clinic, Cleveland, Ohio, USA. Hauptthemen laut MEDLINE: Telemedicine, COVID-19, SARS-CoV-2, Pandemics. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Before the COVID-19 public health emergency, few genetics providers used telehealth. As a response to this, many genetics providers began conducting telehealth care, referred to as telegenetics, usually with guidance from their institutions but without specific guidance related to the uniqueness of genetic services.
Objectives
The Telegenetics Workgroup of the National Coordinating Center for Regional Genetics Networks convened a panel of experts in the fields of telemedicine, genetics, and genomics to review the existing literature on telegenetics and synthesize best operating practices for medical geneticists, genetic counselors, and metabolic dietitians providing telegenetics services.
Methods
The group searched PubMed using the terms “telegenetics,” “telemedicine + genetics,” and “telehealth + genetics.” The group also reviewed the Northeast Telehealth Resource Center’s telegenetics webliography. Websites were searched, including the American Telemedicine Association’s website, Center for Connected Health Policy, and National Telehealth Resource Center for position statements, standards documents, and guidelines. The group met frequently by videoconference and discussed the literature, and using expert consensus, the group determined best practices in providing telegenetics services.
Results
These telegenetics best practices cover important aspects of telegenetics services, including, but not limited to, ongoing delivery of telegenetics services, use of special technology, legal and regulatory requirements, and considerations regarding special settings and circumstances in which telegenetics may be conducted.
Conclusions
Recognizing the growing use of telegenetics and a future in which telegenetics continues to be part of the regular practice of genetics, this guide informs genetics providers of best practices for delivering telegenetics services to patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Medical Genetics and Genomics, Medical Specialties Institute Cleveland Clinic, Cleveland, Ohio, USA.
- Department of Pediatrics, University of New Mexico, Albuquerque, New Mexico, USA.
- Department of Pediatrics, University of Maryland, Baltimore, Maryland, USA.
- Department of Radiology, Emory University, Atlanta, Georgia, USA.
- Hawaii Department of Health, Honolulu, Hawaii, USA.
- Ferre Institute, Binghampton, New York, USA.
ORCID-Profile: David Flannery
Zitieren
APA
Flannery, D., Alverson, D., Greene, C., Krupsinksi, E., Mann, S., Terry, A., Thomas, J., Lyon, M., Singh, R., Dean, L. W., & NCC Telegenetics Workgroup (2024). Delivering Telegenetics Services: Review and Synthesis of Best Practices. Telemedicine and e-Health. https://doi.org/10.1089/tmj.2024.0110
Vancouver
Flannery D, Alverson D, Greene C, Krupsinksi E, Mann S, Terry A, et al. Delivering Telegenetics Services: Review and Synthesis of Best Practices. Telemedicine and e-Health. 2024. doi:10.1089/tmj.2024.0110
BibTeX
@article{Flannery2024,
author = {Flannery, David and Alverson, Dale and Greene, Carol and Krupsinksi, Elizabeth and Mann, Sylvia and Terry, Alissa and Thomas, Janet and Lyon, Megan and Singh, Rani and Dean, Lori Williamson and NCC Telegenetics Workgroup, NCC Telegenetics Workgroup},
title = {Delivering Telegenetics Services: Review and Synthesis of Best Practices},
journal = {Telemedicine and e-Health},
year = {2024},
doi = {10.1089/tmj.2024.0110}
}
EUVIMED